Patents by Inventor Idhaliz Flores

Idhaliz Flores has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10729693
    Abstract: The present disclosure provides methods for treating a mammal that has endometriosis using a CHRH1 antagonist composition. In some embodiments, the CHRH1 antagonist is antalarmin or an equivalent.
    Type: Grant
    Filed: February 28, 2019
    Date of Patent: August 4, 2020
    Assignees: PONCE MEDICAL SCHOOL FOUNDATION, INC., THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Annelyn Torres-Reveron, Caroline B. Appleyard, Idhaliz Flores
  • Patent number: 10695341
    Abstract: Provided herein are methods of treating and/or preventing endometriosis or symptom thereof, assays for diagnosing/prognosing endometriosis, compositions and formulations for treating and/or preventing endometriosis or symptom thereof, and populations of endometiotic cells, including life-extended populations of cells.
    Type: Grant
    Filed: November 18, 2015
    Date of Patent: June 30, 2020
    Assignees: University of South Florida, Ponce Health Sciences University
    Inventors: Meera Nanjundan, Kyle A. Bauckman, Idhaliz Flores
  • Publication number: 20190388413
    Abstract: Provided herein are methods of treating and/or preventing endometriosis or symptom thereof, assays for diagnosing/prognosing endometriosis, compositions and formulations for treating and/or preventing endometriosis or symptom thereof, and populations of endometiotic cells, including life-extended populations of cells.
    Type: Application
    Filed: November 18, 2015
    Publication date: December 26, 2019
    Applicants: University of South Florida, PONCE HEALTH SCIENCES UNIVERSITY
    Inventors: MEERA NANJUNDAM, KYLE A. BAUCKMAN, IDHALIZ FLORES
  • Publication number: 20190269686
    Abstract: The present disclosure provides methods for treating a mammal that has endometriosis using a CHRH1 antagonist composition. In some embodiments, the CHRH1 antagonist is antalarmin or an equivalent.
    Type: Application
    Filed: February 28, 2019
    Publication date: September 5, 2019
    Inventors: Annelyn Torres-Reveron, Caroline B. Appleyard, Idhaliz Flores
  • Publication number: 20090208939
    Abstract: The invention comprises a method of identifying or predicting the predisposition to endometriosis in a female subject comprising determining the level of gene expression of at least one differentially-expressed gene or protein or peptide of peripheral blood leukocytes in a sample of peripheral blood leukocytes or peripheral blood in a subject to provide a first value, determining the level of gene expression of the at least one differentially-expressed gene or protein or peptide of said leukocytes in a control or reference standard to provide a second value, and comparing whether there is a difference between the first value and second value.
    Type: Application
    Filed: December 9, 2005
    Publication date: August 20, 2009
    Inventors: Idhaliz Flores, Spyro Mousses, Ester Rozenblum